The AIDS Malignancy Program supports pre-clinical and clinical
studies for the treatment of cancer in HIV+ and immunocompromised patients. The
AMP also supports resources for preclinical and translational/interdisciplinary
studies including a tissue repository of well characterized specimens collected
from HIV+ and HIV- patients, and infrastructure at institutions that receive
significant AIDS funding.
NOW AVAILABLE: 10th International Conference On Malignancies in AIDS and Other Acquired Immunodeficiencies: Basic, Epidemiologic and Clinical Research
2006 Program Book
Announcing the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI)
Date: October 6-7, 2008
Location: Lister Hill Center Auditorium, National Library of Medicine, NIH, Bethesda, Maryland
Online abstract submission and registration for the 11th ICMAOI can be found at:
http://www.blsmeetings.net/11thICMAOI/
FUNDING OPPORTUNITIES:
PA-06-338: R21 FOA Component of PA-04-157
NOT-CA-06-023: Notice of Availability of Administrative Supplements for Studies of Cancer in HIV/AIDS
Instructions for Applying to NOT-CA-06-023 (MS Word)
PA-04-157: Research on Malignancies in AIDS and Acquired Immune Suppression
Archives
| 
